Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection

  • Islam Meijri Pneumology Department, Military Hospital, Tunis, Tunisia
  • Nouha Boubaker Pneumology Department, Military Hospital, Tunis, Tunisia
  • Tasnim Znegui Pneumology Department, Military Hospital, Tunis, Tunisia
  • Selsabil Daboussi Pneumology Department, Military Hospital, Tunis, Tunisia
  • Chiraz Aichaouia Pneumology Department, Military Hospital, Tunis, Tunisia
  • Samira Mhamdi Pneumology Department, Military Hospital, Tunis, Tunisia
  • Zied Moatemri Pneumology Department, Military Hospital, Tunis, Tunisia
DOI: https://doi.org/10.12890/2022_003475

Keywords

COVID-19, haemoptysis, embolisation

Abstract

Background: Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations.

Case description: We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successful management using endovascular embolization.

Discussion: Life-threatening massive haemoptysis has rarely been reported as the only manifestation of COVID-19. Embolisation was the therapeutic option chosen to manage this emergency. 

VIEW THE ENTIRE ARTICLE

References

  • Peys E, Stevens D, Weygaerde YV, Malfait T, Hermie L, Rogiers P, et al. Haemoptysis as the first presentation of COVID-19: a case report. BMC Pulm Med 2020;20(1):275.
  • Yu C, Lei Q, Li W, Wang X, Li W, Liu W. Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience. J Infect Public Health 2020;13(9):1202–1209.
  • Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect 2020;53(3):404–412.
  • Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623.
  • Argun Baris S, Coskun IS, Selvi G, Boyaci H, BasyigitI. Case series of COVID-19 presenting with massive hemoptysis. Turk Thorac J 2020;21(6):454–456.
  • Shi F, Yu Q, Huang W, Tan C. 2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features. Korean J Radiol 2020;21(5):537.
  • Jajodia S, Goenka U, Jash D, Tiwary I, Goenka MK. Endovascular management of massive hemoptysis due to COVID-19 related pulmonary artery pseudoaneurysm: a rare entity. Radiol Case Rep 2021;16(11):3597–3601.
  • Rott G, Boecker F, Maurer C, Sellmann T. Massive hemoptysis two months after an otherwise mild SARS-CoV-2 disease (COVID-19) treated with bronchial artery embolization - a case report. Radiol Case Rep 2022;17(3):918–921.
  • Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020;77(2):198–209.
  • Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J 2020;41(19):1858–1858.
  • Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med 2020;38(7):1544.e1–1544.e3.

    • Published: 2022-08-01

    Issue: 2022: Vol 9 No 8 (view)

    Section: Articles

    How to cite:
    1.
    Meijri I, Boubaker N, Znegui T, Daboussi S, Aichaouia C, Mhamdi S, Moatemri Z. Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection. EJCRIM 2022;9 doi:10.12890/2022_003475.

    Most read articles by the same author(s)